Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
Pitofsky Jason sold 4,062 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Nov 4, 2026 · Filed Nov 6, 2026
On Nov 4, 2026, Pitofsky Jason (SVP Controller) sold 4,062 Regeneron Pharmaceuticals, Inc. shares at an average US$942.19 for US$3.83M, leaving 0 shares. Filed Nov 6, 2026 (Form 4).
- Sold
- 4,062 shares
- Price
- US$942.19 average (US$939.57 to US$950.76)
- Value
- US$3.83M
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- SVP Controller
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | Common Stock | Option exercise | 1,500 | US$726.53 | 5,772 | Direct |
| Nov 4, 2026 | Common Stock | Option exercise | 1,478 | US$644.54 | 7,250 | Direct |
| Nov 4, 2026 | Common Stock | Option exercise | 905 | US$492.00 | 8,155 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 439 | US$939.57 | 7,716 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 575 | US$940.46 | 7,141 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 982 | US$941.58 | 6,159 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 1,215 | US$942.31 | 4,944 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 529 | US$943.53 | 4,415 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 108 | US$944.22 | 4,307 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 35 | US$945.61 | 4,272 | Direct |
| Nov 4, 2026 | Common Stock | Sale | 179 | US$950.76 | 0 | Indirect |
Source
Download original · View original at SEC
Related
- Regeneron Pharmaceuticals, Inc.
- Pitofsky Jason
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · Murphy Andrew J · Nov 18, 2026
- Form 4 · Sing George L · Nov 18, 2026
- Form 4 · McCourt Marion · Nov 18, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026